A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.
about
In vitro and in vivo models for the study of oral delivery of nanoparticlesRecent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.Chitosan-Alginate Microcapsules Provide Gastric Protection and Intestinal Release of ICAM-1-Targeting Nanocarriers, Enabling GI Targeting In Vivo.Application of in situ polymerization for design and development of oral drug delivery systems.Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery.Insulin therapies: Current and future trends at dawn.Peptide pills for brain diseases? Reality and future perspectives.Oral delivery of therapeutic proteins and peptides: a review on recent developments.A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery.Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors.The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.Chitosan/Cyclodextrin/TPP Nanoparticles Loaded with Quercetin as Novel Bacterial Quorum Sensing Inhibitors.Characterization of protein and peptide binding to nanogels formed by differently charged chitosan derivatives.The construction of tissue-engineered blood vessels crosslinked with adenosine-loaded chitosan/β-cyclodextrin nanoparticles using a layer-by-layer assembly method.Glutathione: Antioxidant Properties Dedicated to Nanotechnologies.Chitosan-Based Nanoparticulates for Oral Delivery of Biopharmaceuticals
P2860
Q26829514-D9CC9609-D27F-4936-BEF4-20CD87E7A14DQ34733812-1CE76675-FDBF-426E-9DB3-D8392521A668Q36367986-762B0026-D295-4B48-A979-557189AD555EQ37051502-4D235588-A56D-46B5-AE9A-F6A5F6C02849Q37808382-F512449C-E1CC-49A4-BC92-18835ACA28BAQ37861223-9737522A-3496-4FE7-8D5C-866DE0D1CE1FQ38089594-5ACFA1C1-99A1-488D-86FC-A426071B9FD4Q38096036-BE83F27F-F08F-4FB9-B13A-52B4D70F1519Q38122734-882B0D88-1481-4B3B-BB46-CFD6E6DE0353Q38225019-13847843-9FE9-4A33-9BD5-776096989CC1Q39212810-4C29BC64-15D8-47F6-9FA2-DE1BDB0C834DQ39424092-FE6BD51E-F720-4881-AD5E-EB904F9B4053Q40741687-CF8EF4AA-0E81-4247-A93F-69922006FC18Q46504973-C3F97C0D-CDCF-4FE2-A1F5-F18867D40A16Q50001416-C32E465B-8DB0-4380-AF74-503D045A8079Q50860766-4470EB1E-C4FB-4783-A792-3547DDD3122AQ53521373-FA4D2A00-2C90-4D06-9B06-7C00FFAA13A5Q55001140-DC6B89DE-82E4-4F5B-8087-DDE217E64A67Q57570844-169C2731-26A1-46D7-B17C-57B519510C96
P2860
A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A comparative study of chitosa ...... al delivery of small peptides.
@en
A comparative study of chitosa ...... al delivery of small peptides.
@nl
type
label
A comparative study of chitosa ...... al delivery of small peptides.
@en
A comparative study of chitosa ...... al delivery of small peptides.
@nl
prefLabel
A comparative study of chitosa ...... al delivery of small peptides.
@en
A comparative study of chitosa ...... al delivery of small peptides.
@nl
P2093
P50
P1476
A comparative study of chitosa ...... al delivery of small peptides.
@en
P2093
Angela Lopedota
Eliana Ieva
Massimo Franco
Nicola Cioffi
P356
10.1016/J.EJPB.2010.01.010
P407
P577
2010-01-25T00:00:00Z